Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents.

Saved in:
Bibliographic Details
Title: Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents.
Authors: Kowalczyk OS; Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King´s College London, De Crespigny Park, London SE5 8AF, UK. Electronic address: olivia.kowalczyk@kcl.ac.uk., Cubillo AI; Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King´s College London, De Crespigny Park, London SE5 8AF, UK; Jacobs Center for Productive Youth Development, Zurich Center for Neuroeconomics, University of Zürich, Switzerland., Smith A; Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King´s College London, De Crespigny Park, London SE5 8AF, UK., Barrett N; Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King´s College London, De Crespigny Park, London SE5 8AF, UK., Giampietro V; Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King´s College London, UK., Brammer M; Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King´s College London, UK., Simmons A; Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King´s College London, UK; Centre for Neurodegeneration Research, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK; NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Trust and Institute of Psychiatry, Psychology & Neuroscience, King's College, London, UK., Rubia K; Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King´s College London, De Crespigny Park, London SE5 8AF, UK.
Source: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2019 Oct; Vol. 29 (10), pp. 1102-1116. Date of Electronic Publication: 2019 Jul 26.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9111390 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7862 (Electronic) Linking ISSN: 0924977X NLM ISO Abbreviation: Eur Neuropsychopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-7862
DOI:10.1016/j.euroneuro.2019.07.139